Ivonescimab for lung cancer fails cost-effectiveness test in China at current prices
A new economic evaluation published in BMC Health Services Research concludes that ivonescimab plus chemotherapy, an emerging first-line option for ...
A new economic evaluation published in BMC Health Services Research concludes that ivonescimab plus chemotherapy, an emerging first-line option for ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine